 |
|
Erythropoietic Protoporphyria With Hepatic Cirrhosis
Max M. Wells, MD;
Loren E. Golitz, MD;
Brice J. Bender, MD
Arch Dermatol. 1980;116(4):429-432.
Abstract
 Cholestatic jaundice and rapidly deteriorating hepatic function developed in a 19-year-old man with a lifelong history of photosensitivity. Laboratory studies revealed the characteristic increased erythrocyte and fecal protoporphyrin levels of erythropoietic protoporphyria. Progressive hepatic failure was treated by orthotopic liver transplantation six months after the first clinical indication of hepatic dysfunction. Characteristic light microscopic, fluorescence microscopic, and electron microscopic findings of erythropoietic protoporphyria were present in skin and liver. Four weeks after liver transplantation, the patient died of disseminated candidiasis. At autopsy, the donor liver had no microscopic evidence of protoporphyrin accumulation, although tissue protoporphyrin levels were mildly elevated.
(Arch Dermatol 116:429-432, 1980)
Author Affiliations
From the Departments of Dermatology (Drs Wells and Golitz) and Pathology (Drs Wells, Golitz, and Bender), University of Colorado Health Sciences Center, and the Denver General Hospital (Dr Golitz), Denver. Dr Wells is a Dermatopathology Fellow.
Footnotes
Accepted for publication Oct 25, 1979.
Reprints not available.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Liver disease in erythropoietic protoporphyria: insights and implications for management
Anstey and Hift
Postgrad. Med. J. 2007;83:739-748.
FULL TEXT
Liver disease in erythropoietic protoporphyria: insights and implications for management
Anstey and Hift
Gut 2007;56:1009-1018.
FULL TEXT
Iron Therapy for Hepatic Dysfunction in Erythropoietic Protoporphyria
GORDEUK et al.
ANN INTERN MED 1986;105:27-31.
ABSTRACT
Erythropoietic Protoporphyria Terminating in Liver Failure
Romslo et al.
Arch Dermatol 1982;118:668-671.
ABSTRACT
|
